Cargando…
HIV 2-LTR experiment design optimization
Clinical trials are necessary in order to develop treatments for diseases; however, they can often be costly, time consuming, and demanding to the patients. This paper summarizes several common methods used for optimal design that can be used to address these issues. In addition, we introduce a nove...
Autores principales: | Cannon, LaMont, Vargas-Garcia, Cesar A., Jagarapu, Aditya, Piovoso, Michael J., Zurakowski, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224063/ https://www.ncbi.nlm.nih.gov/pubmed/30408070 http://dx.doi.org/10.1371/journal.pone.0206700 |
Ejemplares similares
-
An Integrated Spatial Dynamics—Pharmacokinetic Model Explaining Poor Penetration of Anti-retroviral Drugs in Lymph Nodes
por: Jagarapu, Aditya, et al.
Publicado: (2020) -
Modelling HIV-1 2-LTR dynamics following raltegravir intensification
por: Luo, Rutao, et al.
Publicado: (2013) -
Optimal Antiviral Switching to Minimize Resistance Risk in HIV Therapy
por: Luo, Rutao, et al.
Publicado: (2011) -
HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics
por: Luo, Rutao, et al.
Publicado: (2012) -
Persistence of an intact HIV reservoir in phenotypically naive T cells
por: Venanzi Rullo, Emmanuele, et al.
Publicado: (2020)